REAL-LIFE EXPERIENCE WITH POMALIDOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA

被引：0
|
作者：
Cubillas, Garcia de la Torre Damian [1 ]
Inigo, Rodriguez Belen [1 ]
Alfayate, Lobo Ana [1 ]
Menendez, Cuevas Marina [1 ]
Bolanos, Calderon Estefania [1 ]
Medina, Salazar Sissy Fiorella [1 ]
Mateo, Morales Marta [1 ]
Pena, Cortijo Ascension [1 ]
Perez, Lopez Cristina [1 ]
Polo, Zarzuela Marta [1 ]
Calo, Perez Aida [1 ]
Colas, Lahuerta Blanca [1 ]
Gomez, Alvarez Miguel [1 ]
Escribano, Serrat Silvia [1 ]
Estival, Monteliu Pablo [1 ]
Gulino, Horacio [1 ]
Daorta, Melisa [1 ]
Moreno, Paredes Nahir Daniela [1 ]
Benavente, Cuesta Celina [1 ]
机构：
[1] Hosp Clin San Carlos, Madrid, Spain
来源：
HAEMATOLOGICA | 2020年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO-027
引用
下载
收藏
页码：151 / 151
页数：1
相关论文
共 50 条
  • [31] Oprozomib, pomalidomide, and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma
    Shah, Jatin
    Usmani, Saad
    Stadtmauer, Edward A.
    Rifkin, Robert M.
    Berenson, James R.
    Berdeja, Jesus G.
    Lyons, Roger M.
    Klippel, Zandra
    Chang, Yu-Lin
    Niesvizky, Ruben
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (09): : 570 - +
  • [32] Bendamustine-Bortezomib-Dexamethasone (BVD) in the Management of Relapsed and Refractory Multiple Myeloma: A Real-Life Experience
    Cerchione, Claudio
    Catalano, Lucio
    Pareto, Anna Emanuele
    Basile, Santina
    Marano, Luana
    Peluso, Ilaria
    Simeone, Luigia
    Vitagliano, Orsola
    Palmieri, Salvatore
    Rocco, Stefano
    Ferrara, Felicetto
    Pane, Fabrizio
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E60 - E61
  • [33] BENDAMUSTINE-BORTEZOMIB-DESAMETASONE (BVD) IN THE MANAGEMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A REAL-LIFE EXPERIENCE
    Cerchione, C.
    Catalano, L.
    Pareto, A. E.
    Basile, S.
    Marano, L.
    Peluso, I.
    Simeone, L.
    Vitagliano, O.
    Palmieri, S.
    Ferrara, F.
    Pane, F.
    HAEMATOLOGICA, 2016, 101 : 792 - 792
  • [34] Bendamustine-Bortezomib-Dexametasone (BVD) in the Management of Relapsed and Refractory Multiple Myeloma: A Real-Life Experience
    Cerchione, Claudio
    Catalano, Lucio
    Pareto, Anna Emanuele
    Basile, Santina
    Marano, Luana
    Peluso, Ilaria
    Simeone, Luigia
    Vitagliano, Orsola
    Palmieri, Salvatore
    Rocco, Stefano
    Romano, Alessandra
    Ferrara, Felicetto
    Pane, Fabrizio
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S343 - S343
  • [35] Pomalidomide for the treatment of relapsed and refractory multiple myeloma
    Guidetti, Anna
    Prada, Claudia Paba
    Laubach, Jacob P.
    Varga, Cindy
    Maglio, Michelle E.
    McKenney, Mary
    Doss, Deborah
    Schlossman, Robert L.
    Mitsiades, Constantine
    Hideshima, Teru
    Gorgun, Gullu T.
    Ghobrial, Irene M.
    Raje, Noopur
    Munshi, Nikhil
    Anderson, Kenneth C.
    Richardson, Paul G.
    EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (10): : 1089 - 1108
  • [36] Carfilzomib, lenalidomide, and dexamethasone in relapsed refractory multiple myeloma: a prospective real-life experience of the Regional Tuscan Myeloma Network
    Antonioli, Elisabetta
    Pilerci, Sofia
    Attucci, Irene
    Buda, Gabriele
    Gozzetti, Alessandro
    Candi, Veronica
    Simonetti, Federico
    Del Giudice, Maria Livia
    Ciofini, Sara
    Staderini, Michela
    Grammatico, Sara
    Buzzichelli, Alessandra
    Messeri, Maria
    Bocchia, Monica
    Galimberti, Sara
    Vannucchi, Alessandro. M. M.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [37] Pomalidomide: A Review in Relapsed and Refractory Multiple Myeloma
    Sheridan M. Hoy
    Drugs, 2017, 77 : 1897 - 1908
  • [38] Tolerability and safety of real-world use of pomalidomide in patients with relapsed/refractory multiple myeloma
    Usami, Eiseki
    Kimura, Michio
    Takenaka, Shoya
    Iwai, Mina
    Teramachi, Hitomi
    Yoshimura, Tomoaki
    MOLECULAR AND CLINICAL ONCOLOGY, 2019, 10 (02) : 293 - 298
  • [39] The efficacy and safety of pomalidomide in relapsed/refractory multiple myeloma in a "real-world" study: Polish Myeloma Group experience
    Charlinski, Grzegorz
    Grzasko, Norbert
    Jurczyszyn, Artur
    Janczarski, Mariusz
    Szeremet, Agnieszka
    Waszczuk-Gajda, Anna
    Bernatowicz, Pawel
    Swiderska, Alina
    Guzicka-Kazimierczak, Renata
    Lech-Maranda, Ewa
    Szczepaniak, Andrzej
    Wichary, Ryszard
    Dmoszynska, Anna
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (03) : 354 - 361
  • [40] Pegfilgrastim in primary prophylaxis of febrile neutropenia during chemotherapy of relapsed and refractory multiple myeloma: a real-life experience
    Cerchione, Claudio
    Catalano, Lucio
    Pareto, Anna Emanuele
    Picardi, Marco
    Pane, Fabrizio
    SUPPORTIVE CARE IN CANCER, 2015, 23 (02) : 301 - +
12345